Our aim is to revolutionize care for people and planet. We drive change that improves the health and wellbeing of patients and those who care for them – while reducing the environmental footprint of healthcare and the life sciences.
Sterile, cleanroom gloves with beaded anti-slip cuffs and curved fingers are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments. Adviced to be worn in combination with the Biogel™ PI Micro Tech Indicator Underglove to form a breach indication system.
Sterile, blue cleanroom undergloves with beaded cuffs and curved fingers are made to be worn in combination with the Biogel™ PI Tech overglove to form a breach indication system. The gloves are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments.
Sterile, cleanroom gloves with beaded anti-slip cuffs and curved fingers are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments. Adviced to be worn in combination with the Biogel™ PI Tech Indicator Underglove to form a breach indication system.
Sterile, blue cleanroom undergloves with beaded cuffs and curved fingers are made to be worn in combination with the Biogel™ NeoTech overglove to form a breach indication system. The gloves are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments.
Sterile, blue cleanroom undergloves with beaded cuffs and curved fingers are made to be worn in combination with the Biogel™ PI Micro Tech overglove to form a breach indication system. The gloves are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments.
Sterile cleanroom gloves with beaded cuffs and curved fingers are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments. Adviced to be worn in combination with the Biogel™ NeoTech Indicator™ Underglove to form a breach indication system.
Sterile durable all-purpose critical environment glove. It offers excellent barrier protection as well as fit, feel and comfort . It has been tested and cleared for use with chemotherapy agents.
L'innovation est au cœur de ce que nous sommes en tant qu'entreprise. Depuis 1849, Mölnlycke est à l'avant-garde du changement, avec des innovations qui améliorent la qualité de vie des patients et de ceux qui les soignent, tout en réduisant l'impact environnemental des soins de santé et des sciences de la vie. Nous nous associons à ceux qui cherchent à façonner l'avenir des soins, non seulement pour résoudre les problèmes d'aujourd'hui, mais aussi pour relever les défis de demain. À l'avenir, nous nous appuierons sur notre fier héritage pour continuer à révolutionner les soins aux personnes et à la planète.
Mölnlycke emploie plus de 8 000 personnes. Le siège de l'entreprise se trouve à Göteborg, en Suède, et nous sommes présents dans plus de 100 pays à travers le monde. Depuis 2007, l'entreprise fait partie d'Investor AB, un propriétaire engagé d'entreprises mondiales de haute qualité, fondé par la famille Wallenberg en 1916.
